Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc tropism assay optimization study
2010-018709-12Phase 3Completed
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Virological response at 48 weeks. Started Jul 2010; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-018709-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018709-12.